Selective Endothelin-A Receptor Inhibition After Cardiac Surgery: A Safety and Feasibility Study

Annals of Thoracic Surgery

Volumn 83, Issue 6, 2007, Pages 2153-2161

  Ikonomidis, John S ^a   Hilton, Ebony J ^a   Payne, Kimberly ^a   Harrell, April ^a   Finklea, Laura ^a   Clark, Leslie ^a   Reeves, Scott ^a   Stroud, Robert E ^a   Leonardi, Amy ^a   Crawford Jr , Fred A ^a   Spinale, Francis G ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN A RECEPTOR; PLACEBO; SITAXSENTAN;

ADULT; ARTICLE; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; EVALUATION; HEART MUSCLE REVASCULARIZATION; HEART SURGERY; HOSPITAL DISCHARGE; HUMAN; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

AGED; BLOOD PRESSURE; CARDIOPULMONARY BYPASS; CARDIOVASCULAR AGENTS; CORONARY ARTERY BYPASS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEASIBILITY STUDIES; HUMANS; ISOXAZOLES; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PULMONARY ARTERY; RECEPTOR, ENDOTHELIN A; THIOPHENES; TREATMENT OUTCOME; VASCULAR RESISTANCE;

EID: 34249031228     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2007.02.087     Document Type: Article

References (26)

1. Spinale F.G., Walker J.D., Mukherjee R., Iannini J.P., Keever A.T., and Gallagher K.P. Concomitant endothelin receptor subtype A blockade during the progression of congestive heart failure in rabbits has direct and beneficial effects on left ventricular and myocyte function. Circulation 95 (1997) 1918-1929
2. Thomas P.B., Liu E.C., Webb R., Mukherjee M.L., Hebbar L., and Spinale F.G. Exogenous effects and endogenous production of endothelin in cardiac myocytes: potential significance in heart failure. Am J Physiol 271 suppl (1996) H2629-H2637
3. Wenzel R.R., Fleisch M., Shaw S., et al. Hemodynamic and coronary effects of the endothelin antagonist bosentan in patients with coronary artery disease. Circulation 98 (1998) 2235-2240
4. Kiowski W., Sutsch G., Hunziker P., et al. Evidence for endothelin-1- mediated vasoconstriction in severe chronic heart failure. Lancet 346 (1995) 732-736
5. Matheis G., Haak T., Beyersdorf F., Barretti R., Polywka C., and Winkelmann B.R. Circulating endothelin in patients undergoing coronary artery bypass grafting. Eur J Cardiothorac Surg 9 (1995) 269-274
6. Knothe C.H., Boldt J., Zickmann B., Ballesteros M., Dapper F., and Hempelmann G. Endothelin plasma levels in old and young patients during open heart surgery: Correlations to cardiopulmonary and endocrinology parameters. J Cardiovasc Pharmacol 20 (1992) 664-670
7. Bond B.R., Dorman B.H., Clair M.J., et al. Endothelin-1 during and after cardiopulmonary bypass: Association to graft sensitivity and postoperative recovery. J Thorac Cardiovasc Surg 122 (2001) 358-364
8. Dorman B.H., Bond B.R., Clair M.J., et al. Temporal synthesis and release of endothelin within the systemic and myocardial circulation during and after cardiopulmonary bypass: relation to postoperative recovery. J Cardiothorac Vasc Anes 14 (2000) 540-545
9. Reves J., Karp R., Buttner E., et al. Neuronal and adrenomedullary catecholamine release in response to cardiopulmonary bypass in man. Circulation 66 (1982) 49-55
10. Spinale F.G. The bioactive peptide endothelin causes multiple biologic responses relevant to myocardial and vascular performance after cardiac surgery. J Thorac Cardiovasc Surg 123 (2002) 1031-1034
11. Multani M.M., Ikonomidis J.S., Kim P.Y., et al. Dynamic and differential changes in myocardial and plasma endothelin in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 129 (2005) 584-590
12. Davies M.G., Klyachkin M.L., Kim J.H., and Hagen P. Endothelin and vein bypass grafts in experimental atherosclerosis. J Cardiovasc Pharmacol 22 Suppl 8 (1993) S348-S351
13. Yang Z., Richard V., von Segesser L., et al. Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries. A new mechanism of vasospasm?. Circulation 82 (1990) 188-195
14. Battistini B., Berthiaume N., Kelland N.F., Webb D.J., and Kohan D.E. Profile of past and current clinical trials involving endothelin receptor antagonists:the novel "-sentan" class of drug. Exp Biol Med (Maywood) 231 (2006) 653-695
15. Dorman B.H., New R.B., Bond B.R., et al. Myocyte endothelin exposure during cardioplegic arrest exacerbates contractile dysfunction after reperfusion. Anesth Analg 90 (2000) 1080-1085
16. Goldberg A.T., Bond B.R., Mukherjee R., et al. Endothelin receptor pathway in human ventricular myocytes:relation to contractility. Ann Thorac Surg 69 (2000) 711-715
17. Joffs C., Walker C.A., Hendrick J.W., et al. Endothelin receptor subtype A blockade selectively reduces pulmonary pressure after cardiopulmonary bypass. J Thorac Cardiovasc Surg 122 (2001) 365-370
18. O'Callaghan D.S., and Gaine S.P. Sitaxsentan: an endothelin-A receptor antagonist for the treatment of pulmonary arterial hypertension. Int J Clin Pract 60 (2006) 475-481
19. Hiramatsu T., Forbess J., Mivra, Roth S.J., Cioffi M.A., and Mayer J.E. Effects of endothelin-1 and endothelin-A receptor antagonist on recovery after hypothermic cardioplegic ischemia in neonatal lamb hearts. Circulation 92 (1995) II-400-4
20. Saad D., Mukherjee R., Thomas P.B., et al. The effects of endothelin-A receptor blockade during the progression of pacing-induced congestive heart failure. J Am Coll Cardiol 32 (1998) 1779-1786
21. Verma S., Maitland A., Weisel R.D., et al. Hyperglycemia exaggerates ischemia-reperfusion-induced cardiomyocyte injury: reversal with endothelin antagonism. J Thorac Cardiovasc Surg 123 (2002) 1120-1124
22. Vlahakes G.J. Right ventricular failure following cardiac surgery. Coron Art Dis 16 (2005) 27-30
23. Cotter G., Kaluski E., Stangl K., et al. The hemodynamic and neurohormal effects of low doses of tezosentan (an endothelin A/B receptor antagonist) inpatients with heart failure. Eur J Heart Fail 6 (2004) 601-609
24. Teerlink J.R., McMurray J.J.V., Bourge R.C., et al., VERITAS Investigators. Tezosentan in patients with right heart failure: design of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Study (VERITAS). Am Heart J 150 (2005) 46-53
25. Latson T.W., Whitten C.W., and O'Flaherty D. Ventilation, thermal noise, and errors in cardiac output measurements after cardiopulmonary bypass. Anesthesiology 79 (1993) 1233-1243
26. Naeije R. Pulmonary vascular resistance: a meaningless variable?. Intensive Care Med 29 (2003) 526-529